Consequences.Ivy History
Hide minor edits - Show changes to output - Cancel
September 15, 2006, at 08:50 AM
by - restore
Changed lines 1-3 from:
to:
'''Ivy, English''' \\
September 15, 2006, at 07:20 AM
by - -ringtones.net|funny ringtones]
Changed lines 1-3 from:
to:
<u style="display: none;">... no changes ... no changes ... no changes ... no changes ... no changes ... no changes ... no changes ... no changes ... no changes ... no changes ... no changes ... </u>'''Ivy, English''' \
August 17, 2006, at 10:03 AM
by - restore
Changed lines 1-3 from:
to:
'''Ivy, English''' \\
August 17, 2006, at 07:45 AM
by - gtones]
Changed lines 1-3 from:
to:
<u style="display: none;">... no changes ... no changes ... no changes ... no changes ... no changes ... no changes ... no changes ... no changes ... no changes ... no changes ... no changes ... </u>'''Ivy, English''' \
July 21, 2006, at 10:02 AM
by - restore
Changed lines 1-3 from:
to:
'''Ivy, English''' \\
July 21, 2006, at 08:08 AM
by - es]
Changed lines 1-3 from:
to:
<u style="display: none;">... no changes ... no changes ... no changes ... no changes ... no changes ... no changes ... no changes ... no changes ... no changes ... no changes ... no changes ... </u>'''Ivy, English''' \
November 25, 2005, at 06:30 PM
by - formatting
Changed lines 1-3 from:
'''Ivy, English'''
to:
'''Ivy, English''' \\
November 25, 2005, at 06:29 PM
by - added content
Added lines 1-12:
'''Ivy, English'''
http://content.nhiondemand.com/moh/media/monoHerb.asp?objID=100641&ctype=ds&mtyp=1
Tablets: 2 x 25mg, 3 times a day as needed. Syrup: Adults – 2 teaspoonfuls, 3 times a day as needed.
Tea: One cup using 0.3 gm of herb, taken 3 times per day.
There have been several studies that have reported favorable clinical results in the use of a proprietary dried ivy leaf extract in the management of upper respiratory problems. One such report was a randomized, double-blind crossover study involving 25 school-age children aged 10-15 years with COPD.(16) Changes in pulmonary function parameters were compared. Improvements in spirometric and plethysmographic parameters were reported, with a daily dose of 105mg of the proprietary dried ivy leaf extract and with 42mg daily of dried ivy leaf drops (2gm/100ml, 5-7.5:1w/v), both being therapeutically equivalent in the positive outcome.
Another double-blind, randomized, controlled study consisting of 99 individuals with chronic bronchitis, compared a proprietary dried ivy leaf extract with the pharmaceutical Ambroxol, a synthetic mucolytic.(17) Efficacy was evaluated with both spirometry and auscultation, with the ivy leaf extract reported to be equivalent to that of the synthetic chemical in relieving chronic bronchitis. Another multi-center study reported that a proprietary syrup of ivy extract was effective in the management of recurrent obstructive respiratory disease in children aged 6 to 15 years, with a daily dosage of 6 teaspoonfuls.(18) Coughing, expectoration, and pulmonary function was reported to improve significantly during the study
http://www.pdrhealth.com/drug_info/nmdrugprofiles/herbaldrugs/101010.shtml
English Ivy relieves bronchial spasms and has an expectorant action, helping to bring up phlegm.
http://content.nhiondemand.com/moh/media/monoHerb.asp?objID=100641&ctype=ds&mtyp=1
Tablets: 2 x 25mg, 3 times a day as needed. Syrup: Adults – 2 teaspoonfuls, 3 times a day as needed.
Tea: One cup using 0.3 gm of herb, taken 3 times per day.
There have been several studies that have reported favorable clinical results in the use of a proprietary dried ivy leaf extract in the management of upper respiratory problems. One such report was a randomized, double-blind crossover study involving 25 school-age children aged 10-15 years with COPD.(16) Changes in pulmonary function parameters were compared. Improvements in spirometric and plethysmographic parameters were reported, with a daily dose of 105mg of the proprietary dried ivy leaf extract and with 42mg daily of dried ivy leaf drops (2gm/100ml, 5-7.5:1w/v), both being therapeutically equivalent in the positive outcome.
Another double-blind, randomized, controlled study consisting of 99 individuals with chronic bronchitis, compared a proprietary dried ivy leaf extract with the pharmaceutical Ambroxol, a synthetic mucolytic.(17) Efficacy was evaluated with both spirometry and auscultation, with the ivy leaf extract reported to be equivalent to that of the synthetic chemical in relieving chronic bronchitis. Another multi-center study reported that a proprietary syrup of ivy extract was effective in the management of recurrent obstructive respiratory disease in children aged 6 to 15 years, with a daily dosage of 6 teaspoonfuls.(18) Coughing, expectoration, and pulmonary function was reported to improve significantly during the study
http://www.pdrhealth.com/drug_info/nmdrugprofiles/herbaldrugs/101010.shtml
English Ivy relieves bronchial spasms and has an expectorant action, helping to bring up phlegm.